Wall Street analysts forecast that INC Research Holdings Inc (NASDAQ:INCR) will report $756.76 million in sales for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for INC Research’s earnings. The highest sales estimate is $765.00 million and the lowest is $748.00 million. INC Research posted sales of $262.98 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 187.8%. The firm is expected to issue its next earnings results on Tuesday, February 27th.

According to Zacks, analysts expect that INC Research will report full year sales of $756.76 million for the current year, with estimates ranging from $1.85 billion to $1.93 billion. For the next financial year, analysts forecast that the business will report sales of $3.24 billion per share, with estimates ranging from $3.19 billion to $3.46 billion. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow INC Research.

INC Research (NASDAQ:INCR) last announced its earnings results on Thursday, November 9th. The company reported $0.54 earnings per share for the quarter, missing analysts’ consensus estimates of $0.63 by ($0.09). The business had revenue of $592.21 million during the quarter, compared to the consensus estimate of $604.95 million. INC Research had a positive return on equity of 14.42% and a negative net margin of 4.29%. INC Research’s revenue was up 128.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.64 earnings per share.

Several equities research analysts have weighed in on the company. BidaskClub upgraded INC Research from a “hold” rating to a “buy” rating in a report on Wednesday. Zacks Investment Research cut INC Research from a “buy” rating to a “hold” rating in a research note on Wednesday, October 4th. Mizuho began coverage on INC Research in a research note on Thursday, September 21st. They set a “neutral” rating and a $57.00 price objective for the company. TheStreet cut INC Research from a “b-” rating to a “c” rating in a research note on Monday, December 18th. Finally, Credit Suisse Group began coverage on INC Research in a research note on Wednesday, October 11th. They set an “outperform” rating and a $68.00 price objective for the company. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have given a buy rating to the company. INC Research has a consensus rating of “Hold” and a consensus price target of $50.56.

Several institutional investors have recently bought and sold shares of INCR. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of INC Research by 14.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,765 shares of the company’s stock worth $103,000 after acquiring an additional 228 shares during the period. Pacad Investment Ltd. bought a new stake in shares of INC Research in the second quarter worth $123,000. Riverhead Capital Management LLC bought a new stake in shares of INC Research in the second quarter worth $128,000. Victory Capital Management Inc. grew its holdings in shares of INC Research by 17.6% in the second quarter. Victory Capital Management Inc. now owns 2,377 shares of the company’s stock worth $139,000 after acquiring an additional 356 shares during the period. Finally, Personal Capital Advisors Corp bought a new stake in shares of INC Research in the third quarter worth $234,000. 99.50% of the stock is owned by institutional investors and hedge funds.

INC Research (NASDAQ:INCR) traded up $0.50 on Wednesday, reaching $44.10. The company had a trading volume of 1,067,000 shares, compared to its average volume of 1,080,000. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.99. INC Research has a fifty-two week low of $33.60 and a fifty-two week high of $61.10. The company has a market cap of $4,550.00, a price-to-earnings ratio of -77.37, a price-to-earnings-growth ratio of 1.35 and a beta of 1.09.

ILLEGAL ACTIVITY NOTICE: “$756.76 Million in Sales Expected for INC Research Holdings Inc (INCR) This Quarter” was first posted by American Banking News and is the sole property of of American Banking News. If you are reading this story on another site, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright laws. The legal version of this story can be read at https://www.americanbankingnews.com/2018/01/03/756-76-million-in-sales-expected-for-inc-research-holdings-inc-incr-this-quarter.html.

About INC Research

INC Research Holdings, Inc is a global contract research organization (CRO). The Company focuses on Phase I to Phase IV clinical development services for the biopharmaceutical and medical device industries. The Company operates through two segments: Clinical Development Services and Phase I Services.

Get a free copy of the Zacks research report on INC Research (INCR)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for INC Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for INC Research and related companies with MarketBeat.com's FREE daily email newsletter.